Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes : The HYPOAGE observational study
© 2023 The Authors. Journal of the American Geriatrics Society published by Wiley Periodicals LLC on behalf of The American Geriatrics Society..
BACKGROUND: There is a lack of real-life data regarding the frequency and predictive factors of hypoglycemia in older patients with type 2 diabetes (T2D). This study aimed to determine the frequency and predictors of hypoglycemia in older patients with insulin-treated T2D.
METHODS: This prospective multicenter study included 155 insulin-treated T2D patients aged 75 years and older with ≥2 self-monitoring of blood glucose (SMBG) daily controls. Participants underwent a geriatric and diabetic assessment and received ambulatory blinded continuous glucose monitoring (CGM) for 28 consecutive days with FreeStyle Libre Pro® sensor. Study population (n = 141) has >70% CGM active time. Multivariable logistic regressions were used to identify factors associated with SMBG confirmed hypoglycemia (≥70 mg/dL) and with nocturnal level 2 time below range (glucose concentration <54 mg/dL during ≥15 consecutive min between 0.00 and 6.00 am).
RESULTS: The mean age of the 141 analyzed patients was 81.5 ± 5.3 years and 56.7% were male. The mean baseline HbA1c was 7.9% ± 1.0%. After geriatric assessment, 102 participants (72.3%) were considered as complex and 39 (27.7%) as healthy. The primary endpoint (confirmed SMBG <70 mg/dL) occurred in 37.6% patients. In multivariable analysis, the risk of SMBG-confirmed hypoglycemia was positively associated with a longer duration of diabetes (OR (+1 year) =1.04, (1.00-1.08), p = 0.04) and glycemic variability assessed by CGM (CV %) (OR (+1%) = 1.12, [1.05-1.19], p = <0.001). Nighty-two patients (65.2%) experienced nocturnal time in hypoglycemia (i.e., <54 mg/dL during ≥15 consecutive min between midnight and 6 a.m.). In multivariable analyses, cognitive impairment (OR: 9.31 [2.59-33.4]), heart failure (OR: 4.81 [1;48-15.6]), and depressive disorder (OR: 0.19 [0.06-0.53]) were associated with nocturnal time in hypoglycemia.
CONCLUSION: Nocturnal hypoglycemia is very common and largely underdiagnosed in older patients with insulin-treated T2D. CGM is a promising tool to better identify hypoglycemia and adapt diabetes management in this population.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
---|---|
Enthalten in: |
Journal of the American Geriatrics Society - 71(2023), 7 vom: 22. Juli, Seite 2107-2119 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Boureau, Anne-Sophie [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 18.07.2023 Date Revised 19.07.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/jgs.18341 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM354702610 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM354702610 | ||
003 | DE-627 | ||
005 | 20231226062802.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/jgs.18341 |2 doi | |
028 | 5 | 2 | |a pubmed24n1182.xml |
035 | |a (DE-627)NLM354702610 | ||
035 | |a (NLM)36965179 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Boureau, Anne-Sophie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes |b The HYPOAGE observational study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.07.2023 | ||
500 | |a Date Revised 19.07.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 The Authors. Journal of the American Geriatrics Society published by Wiley Periodicals LLC on behalf of The American Geriatrics Society. | ||
520 | |a BACKGROUND: There is a lack of real-life data regarding the frequency and predictive factors of hypoglycemia in older patients with type 2 diabetes (T2D). This study aimed to determine the frequency and predictors of hypoglycemia in older patients with insulin-treated T2D | ||
520 | |a METHODS: This prospective multicenter study included 155 insulin-treated T2D patients aged 75 years and older with ≥2 self-monitoring of blood glucose (SMBG) daily controls. Participants underwent a geriatric and diabetic assessment and received ambulatory blinded continuous glucose monitoring (CGM) for 28 consecutive days with FreeStyle Libre Pro® sensor. Study population (n = 141) has >70% CGM active time. Multivariable logistic regressions were used to identify factors associated with SMBG confirmed hypoglycemia (≥70 mg/dL) and with nocturnal level 2 time below range (glucose concentration <54 mg/dL during ≥15 consecutive min between 0.00 and 6.00 am) | ||
520 | |a RESULTS: The mean age of the 141 analyzed patients was 81.5 ± 5.3 years and 56.7% were male. The mean baseline HbA1c was 7.9% ± 1.0%. After geriatric assessment, 102 participants (72.3%) were considered as complex and 39 (27.7%) as healthy. The primary endpoint (confirmed SMBG <70 mg/dL) occurred in 37.6% patients. In multivariable analysis, the risk of SMBG-confirmed hypoglycemia was positively associated with a longer duration of diabetes (OR (+1 year) =1.04, (1.00-1.08), p = 0.04) and glycemic variability assessed by CGM (CV %) (OR (+1%) = 1.12, [1.05-1.19], p = <0.001). Nighty-two patients (65.2%) experienced nocturnal time in hypoglycemia (i.e., <54 mg/dL during ≥15 consecutive min between midnight and 6 a.m.). In multivariable analyses, cognitive impairment (OR: 9.31 [2.59-33.4]), heart failure (OR: 4.81 [1;48-15.6]), and depressive disorder (OR: 0.19 [0.06-0.53]) were associated with nocturnal time in hypoglycemia | ||
520 | |a CONCLUSION: Nocturnal hypoglycemia is very common and largely underdiagnosed in older patients with insulin-treated T2D. CGM is a promising tool to better identify hypoglycemia and adapt diabetes management in this population | ||
650 | 4 | |a Observational Study | |
650 | 4 | |a Multicenter Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a basal insulin analogues | |
650 | 4 | |a continuous glucose monitoring | |
650 | 4 | |a glycemic control | |
650 | 4 | |a hypoglycemia | |
650 | 4 | |a older patients | |
650 | 4 | |a type 2 diabetes | |
650 | 7 | |a Insulin |2 NLM | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a Hypoglycemic Agents |2 NLM | |
700 | 1 | |a Guyomarch, Béatrice |e verfasserin |4 aut | |
700 | 1 | |a Gourdy, Pierre |e verfasserin |4 aut | |
700 | 1 | |a Allix, Ingrid |e verfasserin |4 aut | |
700 | 1 | |a Annweiler, Cédric |e verfasserin |4 aut | |
700 | 1 | |a Cervantes, Nathalie |e verfasserin |4 aut | |
700 | 1 | |a Chapelet, Guillaume |e verfasserin |4 aut | |
700 | 1 | |a Delabrière, Isabelle |e verfasserin |4 aut | |
700 | 1 | |a Guyonnet, Sophie |e verfasserin |4 aut | |
700 | 1 | |a Litke, Rachel |e verfasserin |4 aut | |
700 | 1 | |a Paccalin, Marc |e verfasserin |4 aut | |
700 | 1 | |a Penfornis, Alfred |e verfasserin |4 aut | |
700 | 1 | |a Saulnier, Pierre-Jean |e verfasserin |4 aut | |
700 | 1 | |a Wargny, Matthieu |e verfasserin |4 aut | |
700 | 1 | |a Hadjadj, Samy |e verfasserin |4 aut | |
700 | 1 | |a de Decker, Laure |e verfasserin |4 aut | |
700 | 1 | |a Cariou, Bertrand |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the American Geriatrics Society |d 1953 |g 71(2023), 7 vom: 22. Juli, Seite 2107-2119 |w (DE-627)NLM000041769 |x 1532-5415 |7 nnns |
773 | 1 | 8 | |g volume:71 |g year:2023 |g number:7 |g day:22 |g month:07 |g pages:2107-2119 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/jgs.18341 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 71 |j 2023 |e 7 |b 22 |c 07 |h 2107-2119 |